Ancient ritual of blowing into shell ‘could help with common sleep disorder'
The practice of conch blowing, also known as shankh blowing, could improve sleep for patients with obstructive sleep apnoea (OSA) without the need for uncomfortable machinery, according to researchers.
Shankh blowing involves breathing in deeply before exhaling forcefully into a conch, the spiral-shaped shell from a species of sea snail.
The small trial, led by researchers in India, involved 30 people aged with 19 and 65 with OSA.
OSA happens with the walls of the throat relax and narrow or close, with symptoms including choking noises, loud snoring and waking up a lot.
The condition is thought to impact about eight million people in the UK.
For the trial, 16 people were provided with a traditional shankh used in yogic practices and trained in how to use it properly before taking it home, while the remaining 14 people were asked to carry out deep breathing exercises.
Both groups were encouraged to practice for a minimum of 15 minutes five days a week.
They were monitored during sleep and asked questions about sleep quality and how tired they felt during the day.
After six months, the study found those who practised shankh blowing reported sleeping better and were 34% less sleepy during the day.
They also had higher levels of oxygen in the blood during the night and had four to five fewer apnoeas, where breathing stops during sleep, per hour on average.
They also had higher levels of oxygen in their blood during the night.
Dr Krishna K Sharma, of the Eternal Heart Care Centre and Research Institute in Jaipur, India, said: 'The way the shankh is blown is quite distinctive.
'It involves a deep inhalation followed by a forceful, sustained exhalation through tightly pursed lips.
'This action creates strong vibrations and airflow resistance, which likely strengthens the muscles of the upper airway, including the throat and soft palate, areas that often collapse during sleep in people with OSA.
'The shankh's unique spiralling structure may also contribute to specific acoustic and mechanical effects that further stimulate and tone these muscles.'
Continuous positive airway pressure (Cpap) machines are the first line of treatment for OSA.
They involve patients wearing a mask that blows pressurised air into the nose and throat while they sleep.
However, they can be uncomfortable.
Speaking of Cpap, Dr Sharma said: 'While effective, many patients find it uncomfortable and struggle to use it consistently.'
He suggests shankh blowing could be a 'promising alternative'.
'Shankh blowing is a simple low-cost, breathing technique that could help improve sleep and reduce symptoms without the need for machines or medication,' Dr Sharma said.
Researchers are now planning a larger trial involving several hospitals.
Dr Sharma added: 'This next phase will allow us to validate and expand on our findings in a broader, more diverse population and assess how shankh blowing performs over longer periods.
'We also want to study how this practice affects airway muscle tone, oxygen levels and sleep in greater detail.
'We're particularly interested in comparing shankh blowing with standard treatments like Cpap, and in examining its potential help in more severe forms of OSA.'
Reacting to the findings, Professor Sophia Schiza, head of the ERS group on sleep disordered breathing, based at the University of Crete, Greece, said: 'We know that OSA patients have poor quality of sleep, and higher risks of high blood pressure, strokes and heart disease.
'A proportion of patients experience sleepiness during the day.
'While Cpap and other treatments are available based on careful diagnosis of disease severity, there is still need for new treatments.
'This is an intriguing study that shows the ancient practice of shankh blowing could potentially offer an OSA treatment for selected patients by targeting muscles training.
'A larger study will help provide more evidence for this intervention which could be of benefit as a treatment option or in combination with other treatments in selected OSA patients.'
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
The Independent
29 minutes ago
- The Independent
Bird-dinosaur species found with extremely ‘robust' hands
Sign up for our free Health Check email to receive exclusive analysis on the week in health Get our free Health Check email Get our free Health Check email Email * SIGN UP I would like to be emailed about offers, events and updates from The Independent. Read our Privacy notice A new bird-like dinosaur species has been discovered with unusually large and 'robust' clawed hands, shedding more light on early adaptations that led to the evolution of birds. The dinosaur, named Shri rapax, belongs to the dinosaur group called dromaeosauridae, which includes small to medium-sized feathered carnivores considered the closest relatives of birds among dinosaurs. Researchers found the new species based on a fossil dated between 75 and 72 million years ago, likely found in the 2000s in Mongolia. However, scientists are unsure of the exact location from which the specimen was unearthed, as it was illegally poached before 2010, and later retained in private collections in Japan and England before being acquired by the French company Eldonia. 'Based on the documentation associated with the specimen, we tentatively refer it to Ukhaa Tolgod, Mongolia,' they wrote. The specimen likely came from the Djadokhta Formation in the Gobi Desert of Mongolia, known for its rich fossil record, particularly of dinosaurs, which dates back to about 75 to 71 million years ago, according to scientists. 'Here, we describe an exquisitely-preserved velociraptorine dromaeosaurid from the Upper Cretaceous Djadokhta Formation of Mongolia, and refer it to the new species Shri rapax,' researchers wrote. Shri rapax was found to have peculiar vertebral and pelvic features along with powerful hands. It had a 'very stout' thumb and claws which were 'proportionally larger' than in any other dromaeosaurid, according to the study. Holotype of Shri rapax sp. nov. ( Historical Biology (2025) ) The dinosaur also had cranial adaptations hinting it supported a powerful bite. 'The most unusual feature of Shri rapax is the exceptional robustness of the hand,' scientists wrote in the study published in the journal Historical Biology. Researchers suspect the dinosaur's peculiar hands were adaptations that enabled it to target larger prey like the plant-eating dinosaur group ceratopsians. 'We suggest that frequent interactions with the ceratopsians, combined with active anti-predatory behaviour by the latter, could have promoted the evolution of more robust forearms and stockier hands among some Djadokhtan velociraptorines,' scientists wrote in the study. 'If we assume that Shri rapax shared the predatory behaviour of its close relative Velociraptor mongoliensis, the more robust proportions of its hands imply that it was better adapted to target larger and more robust prey than those usually preyed on by Velociraptor,' they wrote. The findings suggest the new species was adapted to handling vertebrate prey larger than those preferred by the other bird-like dinosaurs that roamed the prehistoric Djadokhtan site. These large prey likely also included immature individuals of armoured dinosaurs, scientists say.
The Independent
an hour ago
- The Independent
New ‘remarkable' pancreatic cancer vaccine offers fresh hope for patients
A vaccine that appears to slow the progression of one of the most deadly cancers could be manufactured in bulk, researchers say. The jab has given hope to patients after a trial found it increased the survival of participants with pancreatic cancer. Researchers described the findings as 'remarkable' and have already started testing the efficiency of the jab among a larger group of pancreatic and bowel cancer patients. The jab uses a new type of immunotherapy, designed to improve vaccine delivery to the lymph nodes, which help the body fight infections and disease. Pancreatic and bowel cancers frequently carry a mutation in a gene called KRAS, which plays a key role in tumour growth, and scientists developed the jab to recognise and attack this gene. The study, published in the journal Nature Medicine, tested the jab on 20 patients with pancreatic cancer and five with bowel cancer. When participants were followed up after 20 months, 68 per cent had developed strong immune responses specific to mutant KRAS tumour proteins. Participants who had the strongest immune responses lived and stayed cancer-free for longer than those with weaker responses. Some patients survived about two years and five months after receiving the vaccine. In comparison, just three in 10 people diagnosed with pancreatic cancer survive for a year. Pancreatic cancer has some of the poorest survival rates due to late detection. It doesn't usually cause symptoms in the early stages, and as it grows, it can cause tummy pain, yellowing of the skin, unexplained weight loss and changes in stools. Many patients see their cancer returning even after treatments such as radiotherapy and chemotherapy. But the trial showed the jab could help prevent the cancer from returning for more than 15 months. Unlike other cancer jabs which are personalised to individual patients, this vaccine, ELI-002 2P, has a single version which can be given to all patients meaning it can be manufactured in bulk and given more rapidly. Dr Dani Edmunds, research information manager at Cancer Research UK, said: 'It's promising to see that vaccines could help people with pancreatic and bowel cancer live cancer-free for longer.' 'More research is needed to understand why some people benefit from the vaccine while others don't, so that we can make sure we're beating cancer for everyone,' he added. Professor Richard Sullivan, director of the Centre for Conflict and Health Research at King's College London, has suggested more research is needed. 'There is some interesting science in this study, but this is a long way from proving any sort of clinical utility,' he said.
BBC News
an hour ago
- BBC News
Japan adopts stricter safety rules after deaths
Japanese boxing officials have voted to implement stricter rules on weight loss and to also introduce urine tests following the deaths of two fighters in Shigetoshi Kotari, 28, and featherweight Hiromasa Urakawa, also 28, died after sustaining injuries in separate bouts on the same card on 2 boxers underwent surgery for subdural haematoma - a condition where blood collects between the skull and the the event, the Japan Boxing Commission (JBC) announced all Oriental and Pacific Boxing Federation (OPBF) title bouts will now be 10 rounds instead of Japanese Professional Boxing Association (JPBA), the JBC and gym owners met to discuss the emergency measures on voted to include urine tests to measure dehydration and agreed that ambulances will be required on site, even for non-world title will partner with the governing bodies to ensure they are equipped to perform emergency surgery for head and other will also have to adhere to new rules on how long they must stop sparring during training before a fight."Officials have decided to take all possible measures to ensure that the deaths of these two boxers are not in vain," Tsuyoshi Yasukochi, secretary general of the JBC, said an accident investigation committee will work to find out the cause of the boxers' deaths later in August before updating their guidance on prevention JBC and JPBA are also scheduled to meet with the organisations' doctors and the amateur boxing federation.
